Dermatology · Norman, OK
NPI
1023016169
Since 2005
Specialty
Dermatology
Code 174400000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
2413 Palmer Cir
Norman, OK, 73069
Phone (405) 321-5322
Groups this clinician bills Medicare through
Medicare paid, 2024
$369K
9,589 services
Medicare patients, 2024
2,509
Average age 76
Drug cost, 2024
$1.3M
2,583 prescriptions
Company payments, 2025
$1,760
From 17 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Thomas D Urice was code 99213 (office e&m - established), 2,676 times for 1,911 patients. In total Thomas D Urice billed 9,589 services in 54 codes, and Medicare paid $369K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-05-13.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 2,676 | 1,911 | $50.14 | $134K |
| 17003 Destruction Skin Lesion | Office | 2,161 | 503 | $3.64 | $7,867 |
| 17000 Destruction Skin Lesion | Office | 1,214 | 807 | $28.80 | $35K |
| 17110 Destruction Skin Lesion | Office | 1,095 | 904 | $57.99 | $63K |
| 11102 Skin Biopsy | Office | 708 | 576 | $46.30 | $33K |
| 99212 Office E&M - Established | Office | 658 | 550 | $32.72 | $22K |
| 99214 Office E&M - Established | Office | 186 | 128 | $66.27 | $12K |
| 99203 Office E&M - New | Office | 142 | 142 | $61.50 | $8,732 |
| 11103 Skin Biopsy | Office | 95 | 83 | $28.42 | $2,699 |
| 10040 Removal or Shaving of Skin Growth | Office | 82 | 76 | $62.99 | $5,165 |
| 17261 Destruction Skin Lesion | Office | 74 | 72 | $87.64 | $6,486 |
| 17280 Destruction Skin Lesion | Office | 69 | 62 | $77.82 | $5,369 |
| 17281 Destruction Skin Lesion | Office | 57 | 57 | $110.78 | $6,315 |
| 99202 Office E&M - New | Office | 49 | 49 | $35.31 | $1,730 |
| 17260 Destruction Skin Lesion | Office | 41 | 32 | $57.12 | $2,342 |
By year: 2022 $471K for 10,937 services; 2023 $435K for 9,808 services; 2024 $369K for 9,589 services.
Medicare prescription drug claims, 2024
In 2024, the drug Thomas D Urice prescribed most often to Medicare patients was Triamcinolone Acetonide, with 401 prescriptions and refills. In total Thomas D Urice wrote 2,583 Medicare prescriptions that cost $1.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Triamcinolone Acetonide Generic | 401 | 464 | 283 | $2,945 |
| Hydrocortisone Generic | 276 | 297 | 195 | $3,307 |
| Clobetasol Propionate Generic | 214 | 219 | 138 | $8,530 |
| Doxycycline Hyclate Generic | 206 | 329 | 87 | $4,715 |
| Metronidazole Generic | 185 | 208 | 101 | $9,471 |
| Hydroxyzine Hcl Generic | 131 | 173 | 55 | $2,901 |
| Minoxidil Generic | 115 | 250 | 32 | $551 |
| Dutasteride Generic | 100 | 249 | 30 | $2,831 |
| Clindamycin Phosphate Generic | 60 | 79 | 38 | $1,762 |
| Valacyclovir Valacyclovir Hcl | 51 | 55 | 30 | $851 |
| Dupixent Syringe Dupilumab | 48 | 48 | Under 11 | $188K |
| Dupixent Pen Dupilumab | 48 | 48 | Under 11 | $192K |
| Mupirocin Generic | 46 | 46 | 41 | $299 |
| Tretinoin Generic | 43 | 73 | 24 | $3,375 |
| Fluocinonide Generic | 43 | 43 | 37 | $1,582 |
Brand drugs: 220 claims; generic drugs: 2,363 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Thomas D Urice $1,760 ($1,760 in general payments such as food, travel and fees) from 17 companies. The largest payer was Regeneron Healthcare Solutions, Inc. with $362.
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. REGN | 11 | $362 |
| Genzyme Corporation SNY | 15 | $335 |
| Janssen Biotech, Inc. JNJ | 9 | $302 |
| LEO Pharma Inc. | 14 | $178 |
| UCB, Inc. UCB.BR | 10 | $161 |
| Novartis Pharmaceuticals Corporation NVS | 4 | $78.84 |
| Galderma Laboratories, L.P. GALD.SW | 5 | $76.93 |
| Arcutis Biotherapeutics, Inc. ARQT | 3 | $46.31 |
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 2 | $43.24 |
| Pfizer Inc. PFE | 1 | $36.83 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.